P3 HEALTH PARTNERS INC (PIII) Forecast, Price Target & Analyst Ratings
NASDAQ:PIII • US7444132044
2.23 USD
-0.12 (-5.11%)
Last: Mar 6, 2026, 04:30 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for P3 HEALTH PARTNERS INC (PIII).
Forecast Snapshot
Consensus Price Target
$10.71
+ 380.27% Upside
Next Earnings Forecast
Release DateMar 25, 2026
PeriodQ4 / 2025
EPS Estimate-$9.65
Revenue Estimate364.8M
ChartMill Buy Consensus
80.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$10.71
Upside
+ 380.27%
From current price of $2.23 to mean target of $10.71, Based on 9 analyst forecasts
Low
$8.08
Median
$11.22
High
$13.13
Price Target Revisions
1 Month
0.00%
3 Months
-19.23%
Price Target Summary
9 analysts have analysed PIII and the average price target is 10.71 USD. This implies a price increase of 380.27% is expected in the next year compared to the current price of 2.23.
The average price target has been revised downward by 19.23% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
PIII was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about PIII.
In the previous month the buy percentage consensus was at a similar level.
PIII was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-11-17 | Lake Street | Maintains | Buy -> Buy |
| 2025-04-21 | Lake Street | Maintains | Buy -> Buy |
| 2024-11-20 | TD Cowen | Maintains | Hold -> Hold |
| 2024-04-01 | BTIG | Downgrade | Buy -> Neutral |
| 2024-03-14 | Lake Street | Maintains | Buy -> Buy |
| 2023-09-01 | BTIG | Initiate | Buy |
| 2023-06-30 | TD Cowen | Initiate | Market Perform |
| 2022-01-04 | William Blair | Initiate | Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 25, 2026
PeriodQ4 / 2025
EPS Estimate-$9.65
Revenue Estimate364.8M
Revenue Q2Q-1.59%
EPS Q2Q50.49%
Number of Analysts5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.38%
EPS (1 Month)
0.00%
EPS (3 Months)
-25.42%
Next Earnings Summary
PIII is expected to report earnings on 3/25/2026. The consensus EPS estimate for the next earnings is -9.65 USD and the consensus revenue estimate is 364.80M USD.
The next earnings revenue estimate has been revised upward by 0.38% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.05B 64.65% | 1.266B 20.66% | 1.5B 18.48% | 1.461B -2.63% | 1.678B 14.85% | 1.651B -1.61% | |
| EBITDA YoY % growth | -158.61M 11.48% | -81.255M 48.77% | -226.542M -178.80% | -115.413M 49.05% | -33.915M 70.61% | -12.658M 62.68% | |
| EBIT YoY % growth | -245.9M -30.87% | -167.93M 31.71% | -312.6M -86.15% | -162.282M 48.09% | -107.814M 33.56% | -95.286M 11.62% | |
| Operating Margin | -23.43% | -13.26% | -20.83% | -11.11% | -6.43% | -5.77% | |
| EPS YoY % growth | -149.50 -236.94% | -32.50 78.26% | -46.50 -43.08% | -31.90 31.41% | -21.19 33.58% | -0.27 98.75% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -9.65 50.49% | -7.03 -11.91% | -5.15 17.32% | -9.56 1.16% | -5.74 40.52% |
| Revenue Q2Q % growth | 364.8M -1.59% | 436.31M 16.90% | 419.99M 18.05% | 402.75M 16.65% | 418.51M 14.72% |
| EBITDA Q2Q % growth | -23.358M 47.38% | -16.116M 5.40% | -3.468M -143.29% | -918K -104.85% | 3.468M 114.85% |
| EBIT Q2Q % growth | -43.554M 66.61% | -28.05M 26.35% | -15.096M 55.76% | -45.492M -2.87% | -19.176M 55.97% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.87%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
2.39%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
24.87%
EBIT Next 5 Year
N/A
P3 HEALTH PARTNERS INC / PIII Forecast FAQ
What do analysts expect the price target to be for P3 HEALTH PARTNERS INC (PIII)?
9 analysts have analysed PIII and the average price target is 10.71 USD. This implies a price increase of 380.27% is expected in the next year compared to the current price of 2.23.
When does P3 HEALTH PARTNERS INC (PIII) report earnings?
P3 HEALTH PARTNERS INC (PIII) will report earnings on 2026-03-25, after the market close.
What are the consensus estimates for PIII stock next earnings?
The consensus EPS estimate for the next earnings of P3 HEALTH PARTNERS INC (PIII) is -9.65 USD and the consensus revenue estimate is 364.80M USD.
What is the number of analysts for PIII stock?
The number of analysts covering P3 HEALTH PARTNERS INC (PIII) is 9.